Published in Drugs on January 01, 2008
PTH and Vibration in OSteoporosis Study (PaVOS) | NCT02563353
Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int (2011) 1.50
Teriparatide - Indications beyond osteoporosis. Indian J Endocrinol Metab (2012) 0.89
Osteoporosis in chronic obstructive pulmonary disease. Clin Med Insights Circ Respir Pulm Med (2015) 0.86
Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women. Osteoporos Int (2011) 0.84
Nmp4/CIZ: road block at the intersection of PTH and load. Bone (2009) 0.82
Profile of teriparatide in the management of postmenopausal osteoporosis. Int J Womens Health (2010) 0.82
RAGE supports parathyroid hormone-induced gains in femoral trabecular bone. Am J Physiol Endocrinol Metab (2009) 0.82
More than 6 Months of Teriparatide Treatment Was More Effective for Bone Union than Shorter Treatment Following Lumbar Posterolateral Fusion Surgery. Asian Spine J (2015) 0.81
Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons. J Bone Metab (2015) 0.81
Prospective comparison of the therapeutic effect of teriparatide with that of combined vertebroplasty with antiresorptive agents for the treatment of new-onset adjacent vertebral compression fracture after percutaneous vertebroplasty. Osteoporos Int (2011) 0.80
At least one cyclic teriparatide administration can be helpful to delay initial onset of a new osteoporotic vertebral compression fracture. Yonsei Med J (2014) 0.77
Teriparatide in Fracture Non-Unions. Transl Med UniSa (2014) 0.76
A case report of severe calciphylaxis - suggested approach for diagnosis and treatment. BMC Nephrol (2017) 0.75
Management of glucocorticoids-induced osteoporosis: role of teriparatide. Ther Clin Risk Manag (2009) 0.75
Teriparatide: a novel means to ultimately achieve true regeneration!!! J Clin Diagn Res (2013) 0.75
Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats. Drug Deliv Transl Res (2017) 0.75
Extended-release intramuscular naltrexone. Drugs (2006) 2.75
Tacrolimus: a further update of its use in the management of organ transplantation. Drugs (2003) 1.72
Meropenem: a review of its use in the treatment of serious bacterial infections. Drugs (2008) 1.51
Risperidone: a review of its use in the treatment of irritability associated with autistic disorder in children and adolescents. Paediatr Drugs (2007) 1.48
Trabectedin : a review of its use in the management of soft tissue sarcoma and ovarian cancer. Drugs (2007) 1.24
Atazanavir: a review of its use in the management of HIV-1 infection. Drugs (2009) 1.21
Denosumab: a review of its use in the treatment of postmenopausal osteoporosis. Drugs Aging (2011) 1.21
Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44. Blood (2005) 1.19
Darunavir: a review of its use in the management of HIV infection in adults. Drugs (2009) 1.16
Tocilizumab: a review of its use in the management of rheumatoid arthritis. Drugs (2009) 1.16
Bevacizumab: a review of its use in metastatic colorectal cancer. Drugs (2008) 1.04
Trabectedin: a review of its use in soft tissue sarcoma and ovarian cancer. Drugs (2010) 1.02
Deferasirox : a review of its use in the management of transfusional chronic iron overload. Drugs (2007) 1.02
Vildagliptin: a review of its use in the management of type 2 diabetes mellitus. Drugs (2008) 1.00
Raltegravir: a review of its use in the management of HIV infection in treatment-experienced patients. Drugs (2009) 1.00
Sugammadex: a review of its use in anaesthetic practice. Drugs (2009) 0.99
Trastuzumab: a review of its use in the management of HER2-positive metastatic and early-stage breast cancer. Drugs (2006) 0.96
Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections. Drugs (2008) 0.94
Trastuzumab emtansine: first global approval. Drugs (2013) 0.93
Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia. Drugs (2007) 0.93
Ibrutinib: a review of its use in patients with mantle cell lymphoma or chronic lymphocytic leukaemia. Drugs (2015) 0.92
Eltrombopag. Drugs (2009) 0.92
Dasatinib: a review of its use in the treatment of chronic myeloid leukaemia and Philadelphia chromosome-positive acute lymphoblastic leukaemia. Drugs (2011) 0.92
Escitalopram: a review of its use in the management of major depressive disorder. Drugs (2005) 0.92
Letrozole : in postmenopausal hormone-responsive early-stage breast cancer. Drugs (2006) 0.92
Strontium ranelate: a review of its use in the treatment of postmenopausal osteoporosis. Drugs (2010) 0.92
Desloratadine: an update of its efficacy in the management of allergic disorders. Drugs (2003) 0.91
Rabeprazole: a review of its use in the management of gastric acid-related diseases in adults. Drugs (2009) 0.90
Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence. CNS Drugs (2005) 0.86
Tipranavir: a ritonavir-boosted protease inhibitor. Drugs (2005) 0.86
Rotavirus vaccine RIX4414 (Rotarix): a review of its use in the prevention of rotavirus gastroenteritis. Paediatr Drugs (2009) 0.85
Bevacizumab plus platinum-based chemotherapy: in advanced non-small cell lung cancer. BioDrugs (2009) 0.84
Armodafinil. CNS Drugs (2009) 0.84
Telbivudine: a review of its use in compensated chronic hepatitis B. Drugs (2010) 0.84
Bimatoprost: a pharmacoeconomic review of its use in open-angle glaucoma and ocular hypertension. Pharmacoeconomics (2006) 0.83
Clevidipine: a review of its use in the management of acute hypertension. Am J Cardiovasc Drugs (2009) 0.83
Ocriplasmin: a review of its use in patients with symptomatic vitreomacular adhesion. Drugs (2013) 0.82
Efinaconazole: first global approval. Drugs (2013) 0.82
Spotlight on bicalutamide 150mg in the treatment of locally advanced prostate cancer. Drugs Aging (2007) 0.82
Dronedarone. Drugs (2009) 0.81
Vildagliptin. Drugs (2006) 0.81
Meningococcal quadrivalent (serogroups A, C, W135 and Y) tetanus toxoid conjugate vaccine (Nimenrix™). Drugs (2012) 0.81
Bevacizumab: a review of its use in combination with paclitaxel or capecitabine as first-line therapy for HER2-negative metastatic breast cancer. Drugs (2011) 0.81
Ranolazine: a review of its use in chronic stable angina pectoris. Drugs (2006) 0.81
DTaP-IPV/Hib vaccine (Pentacel). Paediatr Drugs (2008) 0.80
Dasatinib: a guide to its use in chronic myeloid leukemia in the EU. BioDrugs (2013) 0.80
Azithromycin extended release: a review of its use in the treatment of acute bacterial sinusitis and community-acquired pneumonia in the US. Drugs (2007) 0.80
Bicalutamide 150mg: a review of its use in the treatment of locally advanced prostate cancer. Drugs (2006) 0.80
Tramadol extended-release tablets. Drugs (2006) 0.79
Spotlight on dasatinib in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. BioDrugs (2012) 0.79
Spotlight on Trastuzumab in the management of HER2-positive metastatic and early-stage breast cancer. BioDrugs (2006) 0.79
Spotlight on strontium ranelate: in postmenopausal osteoporosis. Drugs Aging (2010) 0.79
Nebivolol: in the treatment of hypertension in the US. Am J Cardiovasc Drugs (2009) 0.79
Dexmethylphenidate extended release: a review of its use in the treatment of attention-deficit hyperactivity disorder. CNS Drugs (2009) 0.79
Degarelix: a review of its use in patients with prostate cancer. Drugs (2014) 0.79
Rosiglitazone : a review of its use in type 2 diabetes mellitus. Drugs (2007) 0.79
Abatacept. BioDrugs (2006) 0.79
Ustekinumab. BioDrugs (2009) 0.79
Ambrisentan. Drugs (2008) 0.78
Reduced-antigen, combined diphtheria-tetanus-acellular pertussis vaccine, adsorbed (Boostrix) US formulation): use as a single-dose booster immunization in adolescents aged 10-18 years. Paediatr Drugs (2006) 0.78
Omega-3 carboxylic acids (Epanova): a review of its use in patients with severe hypertriglyceridemia. Am J Cardiovasc Drugs (2014) 0.78
Trandolapril/verapamil sustained release: a review of its use in the treatment of essential hypertension. Drugs (2005) 0.78
Spotlight on escitalopram in the management of major depressive disorder. CNS Drugs (2006) 0.77
Salmeterol/fluticasone propionate: a review of its use in asthma. Drugs (2009) 0.77
Spotlight on risperidone in irritability associated with autistic disorder in children and adolescents. CNS Drugs (2008) 0.77
Letrozole: a pharmacoeconomic review of its use in postmenopausal women with breast cancer. Pharmacoeconomics (2006) 0.77
Spotlight on retapamulin in impetigo and other uncomplicated superficial skin infections. Am J Clin Dermatol (2008) 0.77
Omalizumab: a review of its use in the treatment of allergic asthma. BioDrugs (2008) 0.77
DTPa-HBV-IPV/Hib vaccine (Infanrix hexa™): a guide to its use in infants. Paediatr Drugs (2012) 0.77
Lanreotide autogel(®): a review of its use in the treatment of patients with acromegaly. Drugs (2014) 0.76
Travoprost/timolol. Drugs Aging (2006) 0.76
Spotlight on ranolazine in chronic stable angina pectoris. Am J Cardiovasc Drugs (2006) 0.76
Olmesartan medoxomil/amlodipine. Drugs (2009) 0.76
Candesartan cilexetil: a pharmacoeconomic review of its use in chronic heart failure and hypertension. Pharmacoeconomics (2006) 0.76
Caspofungin: in pediatric patients with fungal infections. Paediatr Drugs (2009) 0.76
Lurasidone: a review of its use in adult patients with bipolar I depression. CNS Drugs (2015) 0.75
Octocog alfa (Advate®): a guide to its use in hemophilia A. BioDrugs (2012) 0.75
Tramadol extended-release tablets in moderate to moderately severe chronic pain in adults: profile report. CNS Drugs (2007) 0.75
Erlotinib: as maintenance monotherapy in non-small-cell lung cancer. BioDrugs (2011) 0.75
Pregabalin: in the treatment of postherpetic neuralgia. Drugs Aging (2009) 0.75
Certolizumab pegol: in rheumatoid arthritis. BioDrugs (2009) 0.75
Spotlight on bevacizumab in metastatic colorectal cancer. BioDrugs (2008) 0.75
Extended-release intramuscular naltrexone in alcohol dependence in adults: profile report. CNS Drugs (2007) 0.75
Spotlight on denosumab in postmenopausal osteoporosis. BioDrugs (2011) 0.75
Docetaxel in hormone-refractory metastatic prostate cancer. Drugs (2005) 0.75
Spotlight on teriparatide in osteoporosis. BioDrugs (2009) 0.75